Loading...
Loading...
By Sofía Garduño - Thu, 12/11/2025 - 18:36
This week, Pfizer formalizes a new GLP-1 partnership, PAHO strengthens HIV elimination efforts, and Mexico prepares to vote on e-cigarette oversight
https://mexicobusiness.news/tag/pfizer
More Health
By Sofía Garduño - Wed, 12/10/2025 - 09:38
Pfizer and YaoPharma sign a global agreement to advance GLP-1 candidate YP05002 for weight management, expanding Pfizer’s cardiometabolic pipeline.
By Sofía Garduño - Fri, 11/21/2025 - 12:32
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By Sofía Garduño - Fri, 11/21/2025 - 11:55
Eli Lilly becomes the first drugmaker to hit US$1 trillion, driven by demand for obesity drugs and expectations for orforglipron’s approval next year.
By Sofía Garduño - Thu, 11/06/2025 - 16:03
Pfizer and Novo Nordisk escalate legal battle over Metsera amid rising competition in the obesity treatment market.
By Diego Valverde - Fri, 10/17/2025 - 13:35
Snowflake's AI Data Cloud platform aims to eliminate the complexity and silos that hinder real-world adoption.
By Sofía Garduño - Mon, 09/22/2025 - 11:59
Pfizer will acquire Metsera for US$4.9 billion, expanding its pipeline of obesity and cardiometabolic treatments.
By Sofía Garduño - Tue, 08/05/2025 - 14:44
The US government plans new pharma tariffs, citing trade imbalances and supply chain concerns.
By MBN Staff - Fri, 07/11/2025 - 12:29
Pfizer and Astellas report that XTANDI extends survival in prostate cancer patients with high-risk recurrence, based on the Phase 3 EMBARK study.
By Sofía Garduño - Thu, 06/26/2025 - 10:00
OpenAI examined the role of AI in biosciences, Pfizer advanced efforts to expand vaccine access, and WHO renewed its call for tobacco control.
